- Aethlon Medical (NASDAQ:AEMD) appointed Charles J. Fisher, Jr., M.D., as CEO succeeding Dr. Timothy Rodell, effective as of Oct. 30, 2020; served as board chairman since Nov.2017.
- Mr. Ed Broenniman replaced Dr. Fisher as the chairman, effective as of Oct. 30, 2020.
- "Chuck's depth and breadth of experience in financing, structuring corporate deals, clinical development and regulatory strategy, both in the U.S. and internationally, will be of great value as we prepare Aethlon for the next phase of development," Mr. Broenniman, board chairman commented.